These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 23861189

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion.
    Lakhwani S, Machado P, Pecos P, Coloma M, Rebollo S, Raya JM.
    Transfus Apher Sci; 2011 Aug; 45(1):9-11. PubMed ID: 21723196
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Analysis and perinatal outcome after intravascular transfusion].
    Monico-Ramos R, Ochoa-Flores M, Hernández-Herrera RJ, Flores-Pompa E.
    Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
    [Abstract] [Full Text] [Related]

  • 7. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization.
    Wikman A, Edner A, Gryfelt G, Jonsson B, Henter JI.
    Transfusion; 2007 May; 47(5):911-7. PubMed ID: 17465958
    [Abstract] [Full Text] [Related]

  • 8. Twenty-four cordocenteses in one woman.
    Ulm B, Ulm MR, Deutinger J, Bernaschek G.
    Fetal Diagn Ther; 1999 May; 14(5):283-5. PubMed ID: 10529571
    [Abstract] [Full Text] [Related]

  • 9. Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model.
    Stowell SR, Arthur CM, Girard-Pierce KR, Sullivan HC, Santhanakrishnan M, Natarajan P, Patel SR, Tormey CA, Zimring JC, Hendrickson JE.
    Haematologica; 2015 Oct; 100(10):e394-7. PubMed ID: 26185172
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa.
    Conte R, Cirillo D, Ricci F, Tassi C, Tazzari PL.
    Haematologica; 1997 Oct; 82(1):73-4. PubMed ID: 9107089
    [Abstract] [Full Text] [Related]

  • 13. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD, Gordon MC, Higby K.
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization.
    Bellucci S, Damaj G, Boval B, Rocha V, Devergie A, Yacoub-Agha I, Garderet L, Ribaud P, Traineau R, Socié G, Gluckman E.
    Bone Marrow Transplant; 2000 Feb; 25(3):327-30. PubMed ID: 10673707
    [Abstract] [Full Text] [Related]

  • 17. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome.
    Zwiers C, van Kamp I, Oepkes D, Lopriore E.
    Expert Rev Hematol; 2017 Apr; 10(4):337-344. PubMed ID: 28277805
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Intraperitoneal transfusion in severe fetal hemolytic disease. Experience at the National Institute of Perinatology].
    Sentíes L, Garzon MT, Cabral F, Rosenfeld F, Karchmer S.
    Ginecol Obstet Mex; 1986 Jan; 54():22-4, 26. PubMed ID: 3699489
    [No Abstract] [Full Text] [Related]

  • 20. Fetal cardiocentesis in care of severe Kell immunisation.
    Bakos O, Ewald U, Lindgren PG.
    Fetal Diagn Ther; 1998 Jan; 13(6):372-4. PubMed ID: 9933822
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.